This workshop provides guidance for industry professionals to navigate these challenges effectively. During this half-day event, attendees will gain insights into:
- The current Legislative Landscape: Understand the latest developments in EU regulatory processes.
- Strategies for compliance: Learn best practices for supply chain and production management.
- Material Phase-Out and Replacement: Effective strategies for phasing out restricted materials and identifying alternatives.
- Industry-Specific Solutions: Gain insights into how the medtech sector and other industries are addressing these challenges through innovative practices and collaborative approaches.
- Advanced Analytical Techniques: State-of-the-art methods for analyzing non-aqueous PFAS samples.
- Regulatory Perspectives from the US: Federal and local regulations shaping PFAS restriction in the US.
Organizational information
Wednesday, 28.03.2025
12.30 – 19.00 Uhr
Switzerland Innovation Park Ost
(Lerchenfeldstr.3, St. Gallen)
Program:
12.30 – 13.00Welcome
13.00 – 13.10 Introduction: Jens Ulmer, OST; Arne Jaksch, Jaksch Life Science consulting
13.15 – 13.40 Origin of PFAS restrictions and its implication to industry: tba
13.45 – 14.10 Actual status of the legal process. Update on the RAC and SEAC feedback, Dr. Martijn Beekman EC, DG, REACH
14.15 – 14.40 Best practice for supply chain and production process change: tba
14.45 – 15.15 Coffee Break
15.20 – 15.50 Functional principles of fluorpolymer coating and its sustainable replacement, Dr. Dirk Hegemann, EMPA
15.50 – 16.15 Monitoring of PFAS substitutions regarding safety and sustainability using newly developed prospective SSbD tools, Dr. Peter Wick, EMPA
16.20 – 16.45 Overview and challenges for PFAS quantification, Carmen Ziegler, Metrohm
16.50 – 17.15 PFAS regulation in US, Sharon Elyashiv-Barad, OSTP
17.20 – 17.40 Panel discussion: Moderator tba
17.45 – 19.00 Networking / Apero
